Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Peptidase Inhibition and Analysis, and Nanoplatforms for cancer theranostics.
Radiotherapy meets anticancer metallodrugs.
PLAP Targeted Antibody-Radionuclide Conjugate for Theranostics in Pancreatic Cancer.
<sup>89</sup>Zr/<sup>177</sup>Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer Theranostics.
Radiotherapy Activates Drug-Drug Conjugates for Platinum-Based Combinational Chemotherapy.
Boron neutron capture therapy preserves immune cells and induces robust anti-tumour immunity in preclinical mouse model.
Covalent FAPI Imaging-Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial.
CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma.
Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7/8 prodrugs in mice.
Radiotherapy-Activated Prodrug: Past, Present and Beyond.
Single atom engineering for radiotherapy-activated immune agonist prodrugs.
A Bis-Boron Amino Acid for Positron Emission Tomography and Boron Neutron Capture Therapy.
Ribosomal Incorporation of Fluorosulfonyloxy-<i>l</i>-Phenylalanine into Macrocyclic Peptides for De Novo Target-Specific Covalent Binders.
Porphyrin-Engineered <sup>125</sup>I-Nanoseeds as a Prototype for Immunogenic Brachytherapy.
NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming
Design, Structure Optimization, and Preclinical Evaluation of <sup>188</sup>Re-Labeled FAPI for Targeted Radionuclide Therapy.
Radiation-induced aerobic oxidation <i>via</i> solvent-derived peroxyl radicals.
Bioinspired transfer methylation enabled by a photoactive reagent.
Tumour-specific bioorthogonal synthesis of proteolysis-targeting chimeras and nanoparticles boosts T cell activity.
Radiolabeled Albumin Bound Fibroblast Activation Protein (FAP) Inhibitor-04 Enhances Precision in Renal Fibrosis Diagnosis via PET Imaging.
Supplementary Table 11 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Table 14 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Figure 1 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Table 5 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Figure 2 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Table 7 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Table 1 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Notification to AttendingPhysician from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Clinical Protocol from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Table 3 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma
Supplementary Figure 3 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma